Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study.
Pugliese D, Privitera G, Crispino F, Mezzina N, Castiglione F, Fiorino G, Laterza L, Viola A, Bertani L, Caprioli F, Cappello M, Barberio B, Ricci C, Balestrieri P, Daperno M, Pluchino D, Rizzello F, Scribano ML, Sablich R, Pastorelli L, Manguso F, Variola A, Di Sario A, Grossi L, Armuzzi A; IG‐IBD LIVE Study Group. Pugliese D, et al. Among authors: caprioli f. Aliment Pharmacol Ther. 2022 Jul;56(1):95-109. doi: 10.1111/apt.16923. Epub 2022 May 12. Aliment Pharmacol Ther. 2022. PMID: 35876062 Free PMC article.
Plasma chromogranin a in patients with inflammatory bowel disease.
Sciola V, Massironi S, Conte D, Caprioli F, Ferrero S, Ciafardini C, Peracchi M, Bardella MT, Piodi L. Sciola V, et al. Among authors: caprioli f. Inflamm Bowel Dis. 2009 Jun;15(6):867-71. doi: 10.1002/ibd.20851. Inflamm Bowel Dis. 2009. PMID: 19090560
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F, Bosè F, Rossi RL, Petti L, Viganò C, Ciafardini C, Raeli L, Basilisco G, Ferrero S, Pagani M, Conte D, Altomare G, Monteleone G, Abrignani S, Reali E. Caprioli F, et al. Inflamm Bowel Dis. 2013 Mar-Apr;19(4):729-39. doi: 10.1097/MIB.0b013e318280292b. Inflamm Bowel Dis. 2013. PMID: 23448791
Absence of a role for interleukin-13 in inflammatory bowel disease.
Biancheri P, Di Sabatino A, Ammoscato F, Facciotti F, Caprioli F, Curciarello R, Hoque SS, Ghanbari A, Joe-Njoku I, Giuffrida P, Rovedatti L, Geginat J, Corazza GR, MacDonald TT. Biancheri P, et al. Among authors: caprioli f. Eur J Immunol. 2014 Feb;44(2):370-85. doi: 10.1002/eji.201343524. Eur J Immunol. 2014. PMID: 24338958 Free article.
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.
Monteleone G, Neurath MF, Ardizzone S, Di Sabatino A, Fantini MC, Castiglione F, Scribano ML, Armuzzi A, Caprioli F, Sturniolo GC, Rogai F, Vecchi M, Atreya R, Bossa F, Onali S, Fichera M, Corazza GR, Biancone L, Savarino V, Pica R, Orlando A, Pallone F. Monteleone G, et al. Among authors: caprioli f. N Engl J Med. 2015 Mar 19;372(12):1104-13. doi: 10.1056/NEJMoa1407250. N Engl J Med. 2015. PMID: 25785968 Free article. Clinical Trial.
Interleukin-34 sustains inflammatory pathways in the gut.
Franzè E, Monteleone I, Cupi ML, Mancia P, Caprioli F, Marafini I, Colantoni A, Ortenzi A, Laudisi F, Sica G, Sileri P, Pallone F, Monteleone G. Franzè E, et al. Among authors: caprioli f. Clin Sci (Lond). 2015 Aug;129(3):271-80. doi: 10.1042/CS20150132. Clin Sci (Lond). 2015. PMID: 25800277
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
Mancina RM, Spagnuolo R, Milano M, Brogneri S, Morrone A, Cosco C, Lazzaro V, Russo C, Ferro Y, Pingitore P, Pujia A, Montalcini T, Doldo P, Garieri P, Piodi L, Caprioli F, Valenti L, Romeo S. Mancina RM, et al. Among authors: caprioli f. Inflamm Bowel Dis. 2016 Jan;22(1):134-40. doi: 10.1097/MIB.0000000000000569. Inflamm Bowel Dis. 2016. PMID: 26355465 Free PMC article.
A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study.
Lazzaro C, Cappello M, Cortelezzi C, Costantino G, Fiorino G, Mastronardi M, Giannotta M, Galletti B, Cicala M, Vadalà di Prampero S, Gualberti G, Caprioli F, Gasbarrini A, Fattore G. Lazzaro C, et al. Among authors: caprioli f. Value Health. 2014 Nov;17(7):A370. doi: 10.1016/j.jval.2014.08.841. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200785 Free article. No abstract available.
213 results